D.-W. Kim
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 46
- Lung Cancer Diagnosis and Treatment 8
- Gastric Cancer Management and Outcomes 5
- Oncology 37
- Colorectal Cancer Treatments and Studies 17
- Lung Cancer Research Studies 14
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Tony Mok (7 shared papers)S.-H.I. Ou (6 shared papers)D. Ross Camidge (9 shared papers)Shirish M. Gadgeel (4 shared papers)Walter Bordogna (2 shared papers)Solange Peters (2 shared papers)M. Pérol (3 shared papers)Vlatka Smoljanović (2 shared papers)
- Journals
- Annals of Oncology (40 papers)Journal of Thoracic Oncology (10 papers)Electrochimica Acta (1 paper)Lung Cancer (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
D.-W. Kim
52 papers receiving 1.2k citations
D.-W. Kim's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 844
- Pulmonary and Respiratory Medicine 775
- Cancer Research 202
- Immunology 162
- Automotive Engineering 72
Countries citing papers authored by D.-W. Kim
This map shows the geographic impact of D.-W. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.-W. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.-W. Kim more than expected).
Fields of papers citing papers by D.-W. Kim
This network shows the impact of papers produced by D.-W. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.-W. Kim. The network helps show where D.-W. Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside D.-W. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study Hit paper breakdown → | 2020 | 414 |
| 2 | First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ Hit paper breakdown → | 2021 | 196 |
| 3 | 2004 | 107 | |
| 4 | 2020 | 65 | |
| 5 | 2016 | 51 | |
| 6 | 2016 | 32 | |
| 7 | 2019 | 32 | |
| 8 | 2019 | 22 | |
| 9 | 2018 | 22 | |
| 10 | 2019 | 21 | |
| 11 | 2016 | 18 | |
| 12 | 2019 | 18 | |
| 13 | 2018 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2015 | 15 | |
| 16 | 2016 | 14 | |
| 17 | 2019 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2019 | 11 | |
| 20 | 2019 | 9 |
About D.-W. Kim
D.-W. Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Gastroenterology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (46 papers), Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Research Studies (14 papers), Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer therapeutics and mechanisms (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (844 citations), Pulmonary and Respiratory Medicine (775 citations), Cancer Research (202 citations), Immunology (162 citations) and Automotive Engineering (72 citations). D.-W. Kim has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Tony Mok, S.-H.I. Ou, D. Ross Camidge, Shirish M. Gadgeel, Walter Bordogna, Solange Peters, M. Pérol, Vlatka Smoljanović, Rafał Dziadziuszko and Magalie Hilton. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Electrochimica Acta, Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.